Your browser doesn't support javascript.
loading
Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trials.
Doppenberg, Deesje; van Dam, Jacob L; Han, Youngmin; Bonsing, Bert A; Busch, Olivier R; Festen, Sebastiaan; van der Harst, Erwin; de Hingh, Ignace H; Homs, Marjolein Y V; Kwon, Wooil; Lee, Mirang; Lips, Daan J; de Meijer, Vincent E; Molenaar, I Quintus; Nuyttens, Joost J; Patijn, Gijs A; van Roessel, Stijn; van der Schelling, George P; Suker, Mustafa; Versteijne, Eva; de Vos-Geelen, Judith; Wilmink, Johanna W; van Eijck, Casper H J; van Tienhoven, Geertjan; Jang, Jin-Young; Besselink, Marc G; Groot Koerkamp, Bas.
Afiliação
  • Doppenberg D; Department of Surgery, Amsterdam UMC, Location University of Amsterdam, Amsterdam, the Netherlands.
  • van Dam JL; Cancer Centre Amsterdam, Amsterdam, the Netherlands.
  • Han Y; Department of Radiation Oncology, Amsterdam UMC, Location University of Amsterdam, Amsterdam, the Netherlands.
  • Bonsing BA; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Busch OR; Department of Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea.
  • Festen S; Department of Surgery, Leiden University Medical Centre, Leiden, the Netherlands.
  • van der Harst E; Department of Surgery, Amsterdam UMC, Location University of Amsterdam, Amsterdam, the Netherlands.
  • de Hingh IH; Cancer Centre Amsterdam, Amsterdam, the Netherlands.
  • Homs MYV; Department of Surgery, OLVG, Amsterdam, the Netherlands.
  • Kwon W; Department of Surgery, Maasstad Hospital, Rotterdam, the Netherlands.
  • Lee M; Department of Surgery, Catherina Hospital, Eindhoven, the Netherlands.
  • Lips DJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • de Meijer VE; Department of Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea.
  • Molenaar IQ; Department of Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea.
  • Nuyttens JJ; Department of Surgery, Medisch Spectrum Twente, Enschede, the Netherlands.
  • Patijn GA; Department of Surgery, University of Groningen and University Medical Centre Groningen, Groningen, the Netherlands.
  • van Roessel S; Department of Surgery, Regional Academic Cancer Centre Utrecht, University of Utrecht, Utrecht, the Netherlands.
  • van der Schelling GP; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Suker M; Department of Surgery, Isala Oncology Centre, Zwolle, the Netherlands.
  • Versteijne E; Department of Surgery, Amsterdam UMC, Location University of Amsterdam, Amsterdam, the Netherlands.
  • de Vos-Geelen J; Cancer Centre Amsterdam, Amsterdam, the Netherlands.
  • Wilmink JW; Department of Surgery, Amphia Hospital, Breda, the Netherlands.
  • van Eijck CHJ; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • van Tienhoven G; Cancer Centre Amsterdam, Amsterdam, the Netherlands.
  • Jang JY; Department of Radiation Oncology, Amsterdam UMC, Location University of Amsterdam, Amsterdam, the Netherlands.
  • Besselink MG; Department of Internal Medicine, Division of Medical Oncology, GROW, Maastricht University Medical Centre, Maastricht, the Netherlands.
  • Groot Koerkamp B; Cancer Centre Amsterdam, Amsterdam, the Netherlands.
Br J Surg ; 110(10): 1374-1380, 2023 09 06.
Article em En | MEDLINE | ID: mdl-37440421

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Surg Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Surg Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda